Not provided
Not provided
Not provided
Not provided
unknwon
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Association for the Screening of Cancers in Finistère | OTHER |
| ADECI35 | UNKNOWN |
| ADECARMOR | UNKNOWN |
| ADECAM INDUSTRIE |
Not provided
Not provided
Not provided
Not provided
This is a population-based, prospective, multicenter and open-label study. 12,500 female non-respondents to the uterine cervix smear from 30 to 65 years of age in the context of the organized cervical cancer screening of the uterus, in the 4 Breton departments, will be proposed after stratification by age and socio-economic level at the revival of the cervical cancer of the uterus screening by the structure of management of Rennes, an invitation to the Human Papilloma Virus urine test thanks to the sampling kit sent to the home. It is planned a revival by simple mail after 4 months in one woman out of two who did not respond to this invitation to assess the impact of a recovery. This group represents about 5% of the eligible population in Brittany. The specimen will be sent by post with the signed consent and a questionnaire to the Hospital of Brest in virology laboratory for the detection of Human Papilloma Virus DNA (QPCR) in the urine (HPU test) and typing (LipA). In the case of a positive Human Papilloma Virus test, the woman being tested has a strong incentive to do the cervical cancer of the uterus with her doctor or midwife. In the case of abnormal smear, follow-up continues according to national recommendations to a gynecologist. All the data is collected on a software from the LINKS company, with the networking of the 4 Breton centers, the virology laboratory, and the Anatomy-Cytology-Pathology laboratories in Brittany; this collection will allow after extraction, a statistical analysis of the data. The analysis of the participation rate in this new screening, for each level of the socio-economic level, will allow a comparison with the participation in smear's revival of organized screening, between women's groups according to the socio-economic level of their residential place.
The project will take place over 24 months in 3 phases:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Human Papilloma Virus Test urinary | Experimental | Urinary Test by a kit which is send to the woman's house |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Urinary test | Device | Women use a home urinary test themselves |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of participation in the urinary group | To evaluate the rate of participation in the urinary test group | 18 months |
| Measure | Description | Time Frame |
|---|---|---|
| Participation rate by different parameters | To evaluate the participation rate | 18 months |
| Evaluation of access of the medical network with different indicators | To evaluate the access to the medical network |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Christopher PAYAN | Brest | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000919 | Antibody-Coated Bacteria Test, Urinary |
| ID | Term |
|---|---|
| D005455 | Fluorescent Antibody Technique |
| D007150 | Immunohistochemistry |
| D006651 | Histocytochemistry |
| D003584 | Cytological Techniques |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
| 18 months |
| Evaluation of the Papillomavirus levels of genotype 16 and genotype 18 in the population | To evaluate the Papillomavirus levels of genotype 16 and genotype 18 | 18 months |
| D000291 |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D006652 | Histological Techniques |
| D007159 | Immunologic Tests |
| D003950 | Diagnostic Techniques, Urological |
| D008919 | Investigative Techniques |
| D007158 | Immunologic Techniques |